CAS No. |
2553413-93-5 |
|---|---|
中文名称 |
钠(2R,5R,7R,8R,10R,12aR,14R,15R,15aR,16R)-14-(6-氨基-9H-嘌呤-9-基)-15-氟-7-(5-氟-4-氧代-1,4-二氢-7H-吡咯[2,3-d]嘧啶-7-基)-16-羟基-八氢-12H-5,8-亚甲基呋喃[3,2-l][1,3,6,9,11]五氧杂[2,10]二磷杂环十四烯-2,10-二(硫醇盐)-2,10-二氧化物 |
英文名称 |
Sodium (2R,5R,7R,8R,10R,12aR,14R,15R,15aR,16R)-14-(6-amino-9H-purin-9-yl)-15-fluoro-7-(5-fluoro-4-oxo-1,4-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-16-hydroxyoctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine-2,10-bis(thiolate) 2,10-dioxide |
别名 |
TAK-676;Dazostinag disodium;7-Deazainosine, [P(R)]-2′-deoxy-2′-fluoro-5′-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(3′→5′)-7-fluoro-, cyclic (2′→5′)-nucleotide, sodium salt (1:2) |
标准英文名 |
sodium (2R,5R,7R,8R,10R,12aR,14R,15R,15aR,16R)-14-(6-amino-9H-purin-9-yl)-15-fluoro-7-(5-fluoro-4-oxo-1,4-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-16-hydroxyoctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine-2,10-bis(thiolate) 2,10-dioxide |
MDL No. |
MFCD34647046 |
分子式 |
C21H20F2N8Na2O10P2S2 |
分子量 |
754.49 |
精确分子量 |
754.00 |
SMILES |
NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@@](=O)([S-])O[C@@H]5[C@H](O)[C@@H](CO[P@@](=O)([S-])O[C@H]4[C@H]3F)O[C@H]5N3C=C(F)C4=C3NC=NC4=O)C2=NC=N1.[Na+].[Na+] |
标准SMILES |
[Na+].[Na+].NC1N=CN=C2C=1N=CN2[C@@H]1O[C@@H]2CO[P@@](=O)([S-])O[C@@H]3[C@H](O)[C@@H](CO[P@@](=O)([S-])O[C@H]2[C@H]1F)O[C@H]3N1C=C(F)C2=C1NC=NC2=O |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
DSMDURFDSXGNPW-NZHCJSRUSA-L |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Keep in dark place, Inert atmosphere, Store in freezer, under - 20°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|